379 related articles for article (PubMed ID: 34724663)
1. Fanconi Anemia Complementation Group E, a DNA Repair-Related Gene, Is a Potential Marker of Poor Prognosis in Hepatocellular Carcinoma.
Takahashi J; Masuda T; Kitagawa A; Tobo T; Nakano Y; Abe T; Ando Y; Kosai K; Kobayashi Y; Matsumoto Y; Yoshizumi T; Mori M; Mimori K
Oncology; 2022; 100(2):101-113. PubMed ID: 34724663
[TBL] [Abstract][Full Text] [Related]
2. Analysis of a FANCE Splice Isoform in Regard to DNA Repair.
Bouffard F; Plourde K; Bélanger S; Ouellette G; Labrie Y; Durocher F
J Mol Biol; 2015 Sep; 427(19):3056-73. PubMed ID: 26277624
[TBL] [Abstract][Full Text] [Related]
3. Clinical Significance of
Komatsu H; Masuda T; Iguchi T; Nambara S; Sato K; Hu Q; Hirata H; Ito S; Eguchi H; Sugimachi K; Eguchi H; Doki Y; Mori M; Mimori K
Anticancer Res; 2017 Mar; 37(3):1083-1090. PubMed ID: 28314268
[TBL] [Abstract][Full Text] [Related]
4. The carboxyl terminus of FANCE recruits FANCD2 to the Fanconi Anemia (FA) E3 ligase complex to promote the FA DNA repair pathway.
Polito D; Cukras S; Wang X; Spence P; Moreau L; D'Andrea AD; Kee Y
J Biol Chem; 2014 Mar; 289(10):7003-7010. PubMed ID: 24451376
[TBL] [Abstract][Full Text] [Related]
5. Clinical and biological significance of transcription termination factor, RNA polymerase I in human liver hepatocellular carcinoma.
Komatsu H; Iguchi T; Ueda M; Nambara S; Saito T; Hirata H; Sakimura S; Takano Y; Uchi R; Shinden Y; Eguchi H; Masuda T; Sugimachi K; Eguchi H; Doki Y; Mori M; Mimori K
Oncol Rep; 2016 Apr; 35(4):2073-80. PubMed ID: 26821084
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of FEN1 Is Associated with the Tumor Progression and Prognosis of Hepatocellular Carcinoma.
Zhang Y; Liu X; Liu L; Chen J; Hu Q; Shen S; Zhou Y; Chen S; Xue C; Cui G; Yu Z
Dis Markers; 2020; 2020():2514090. PubMed ID: 32399086
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.
Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q
BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238
[TBL] [Abstract][Full Text] [Related]
8. Chk1-mediated phosphorylation of FANCE is required for the Fanconi anemia/BRCA pathway.
Wang X; Kennedy RD; Ray K; Stuckert P; Ellenberger T; D'Andrea AD
Mol Cell Biol; 2007 Apr; 27(8):3098-108. PubMed ID: 17296736
[TBL] [Abstract][Full Text] [Related]
9. Pan-cancer analysis of the prognostic and immunological role of Fanconi anemia complementation group E.
Zhou Z; Yin H; Suye S; He J; Fu C
Front Genet; 2022; 13():1024989. PubMed ID: 36685883
[TBL] [Abstract][Full Text] [Related]
10. The nuclear accumulation of the Fanconi anemia protein FANCE depends on FANCC.
Léveillé F; Ferrer M; Medhurst AL; Laghmani el H; Rooimans MA; Bier P; Steltenpool J; Titus TA; Postlethwait JH; Hoatlin ME; Joenje H; de Winter JP
DNA Repair (Amst); 2006 May; 5(5):556-65. PubMed ID: 16513431
[TBL] [Abstract][Full Text] [Related]
11. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
12. Objective to identify and verify the regulatory mechanism of DTNBP1 as a prognostic marker for hepatocellular carcinoma.
Cheng X; Li D; Qi T; Sun J; Zhou T; Zheng WV
Sci Rep; 2022 Jan; 12(1):211. PubMed ID: 34997064
[TBL] [Abstract][Full Text] [Related]
13. PTTG1 is involved in TNF-α-related hepatocellular carcinoma via the induction of c-myc.
Lin X; Yang Y; Guo Y; Liu H; Jiang J; Zheng F; Wu B
Cancer Med; 2019 Sep; 8(12):5702-5715. PubMed ID: 31385458
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
[No Abstract] [Full Text] [Related]
15. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
[TBL] [Abstract][Full Text] [Related]
16. Identification of Rad51 as a prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma.
Xu H; Xiong C; Chen Y; Zhang C; Bai D
Bioengineered; 2021 Dec; 12(1):2664-2675. PubMed ID: 34115569
[TBL] [Abstract][Full Text] [Related]
17. Assessing the spectrum of germline variation in Fanconi anemia genes among patients with head and neck carcinoma before age 50.
Chandrasekharappa SC; Chinn SB; Donovan FX; Chowdhury NI; Kamat A; Adeyemo AA; Thomas JW; Vemulapalli M; Hussey CS; Reid HH; Mullikin JC; Wei Q; Sturgis EM
Cancer; 2017 Oct; 123(20):3943-3954. PubMed ID: 28678401
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of EWSR1 (Ewing sarcoma breakpoint region 1/EWS RNA binding protein 1) predicts poor survival in patients with hepatocellular carcinoma.
Jiang W; Wu T; Shi X; Xu J
Bioengineered; 2021 Dec; 12(1):7941-7949. PubMed ID: 34612781
[TBL] [Abstract][Full Text] [Related]
19. Sp1-regulated transcription of RasGRP1 promotes hepatocellular carcinoma (HCC) proliferation.
Zhang X; Zhuang H; Han F; Shao X; Liu Y; Ma X; Wang Z; Qiang Z; Li Y
Liver Int; 2018 Nov; 38(11):2006-2017. PubMed ID: 29655291
[TBL] [Abstract][Full Text] [Related]
20. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.
Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J
Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
